|
1
|
|
|
2
|
- Alcohol Withdrawal is a single condition, ranging from mild to severe
- Benzodiazepine monotherapy is the preferred treatment regardless of
symptoms
- Symptoms graded on a numerical scale, based on severity
|
|
3
|
- Alcohol Withdrawal consists of three distinct symptom clusters
- Drug treatment should be tailored to the symptoms present, using the
agents that best treat those symptoms
- Symptoms graded only for absence or presence, using the AWS Type
Indicator
|
|
4
|
- Tailoring drug treatment to specific symptoms results in a more alert
and cooperative patient
- Avoids dangers associated with over-medication
- Quickly identifies symptoms associated with serious complications
- Reduces complications, morbidity, and mortality
- Easily tracks development of symptoms and responses to treatment
|
|
5
|
- A simple binary scale (symptoms are either present or absent)
- Requires minimal training
- Can be administered in 90 seconds or less
- Guides treatment decisions
- Monitors response to treatment
- Designed for clinical use, not as a research tool
|
|
6
|
- Symptoms
- Uneasiness
- Sense of Foreboding
- Motor Hyperactivity
- Dysphoria
- Enhanced Sensivity to Abrupt Sensory Stimuli
- Lability of Mood
- Anxiety
- Insomnia
- Preferred Agents
- Benzodiazepines
- Carbamazepine
- Valproic Acid
|
|
7
|
- Symptoms
- Chills
- Diaphoresis
- Fever
- Hypermetabolic State
- Hypertension
- Muscle Tremors
- Mydriasis
- Nausea and Vomiting
- Palpitations
- Piloerection
- Tachycardia
- Preferred Agents
- Clonidine
- Beta-Blockers
- Propranolol
- Atenolol
- Labetalol
|
|
8
|
- Symptoms
- Attentional Deficit
- Disorientation
- Hyper-alertness
- Impairment of Short-term Memory
- Impaired Reasoning
- Psyhomotor Agitation
- Visual and Auditory Hallucinations
- Preferred Agents
- Neuroleptics
- Haloperidol
- Fluphenazine
- Risperidone
- Droperidol
|
|
9
|
- Symptoms
- Combination of A, B, and C Symptoms
- Preferred Agents
- Control of Type A Symptoms, Avoiding Benzodiazepines
- Control of Type B Symptoms with Clonidine or Beta-Blockers
- Control of Type C Symptoms with Low-dose Neuroleptics
|
|
10
|
- Agent
- Benzodiazepines
- Carbamazepine
- Valproic Acid
- Clonidine
- Beta-Blockers
- Neuroleptics
|
|
11
|
- Benzodiazepines are not particularly effective at controlling
hyperadrenergic symptoms, including hypertension (Type B AWS)
- Can result in unwanted and prolonged sedation, especially in older
patients
- Can produce cognitive and memory impairments
- Can worsen delirium (Type C AWS)
- Can result in respiratory compromise
|
|
12
|
- Treat lowest level symptoms first
- A, then B, then C except in emergencies
- Re-administer Type Indicator Frequently
- Typical Emergencies
- Severe Type B symptoms, such as severe hypertension, tachycardia
- Severe Type C symptoms (alcohol withdrawal delirium) including
agitation that poses a danger to patient or others
|
|
13
|
- The Acohol Withdrawal Treatment Manual
- provides extensive and detailed information on treatment,
pharmacotherapy, and the AWS Typology
- Focused Treatment Systems website
- http://www.sagetalk.com/
- includes free downloadable copies of Type Indicator, resources on
other topics
|